Last mentioned: Mar 26, 2026
Initial Court Hearings
Expected timeframe for motions to dismiss and initial discovery phases in the respective district courts.
Discovery Phase
Expected commencement of the discovery process if the cases survive initial motions to dismiss.
Lead Plaintiff Deadline
Expected deadline for shareholders to petition the court to serve as lead plaintiff in the case.
Lead Plaintiff Deadline
Estimated 60-day deadline for investors to file motions to be appointed as lead plaintiff in the class actions.
Lead Plaintiff Deadline
Estimated deadline for shareholders to petition the court to lead the litigation.
Lead Plaintiff Deadline
Final date for investors to apply for lead plaintiff status in the litigation.
Lead Plaintiff Deadline
Final date for shareholders to move the court to serve as lead plaintiff in the litigation.
Lead Plaintiff Deadline
Final date for investors to petition the court to serve as lead plaintiff in the consolidated action.
Lead Plaintiff Deadline
Final date for investors to petition the court to lead the Enphase class action.
Lead Plaintiff Deadline (Est)
Anticipated deadline for shareholders to move the court for lead plaintiff appointment.
Secondary Notice
Pomerantz reinforces the filing highlights to ensure broad investor awareness.
Follow-up Disclosure
Secondary announcements highlight the filing and the process for shareholders to join the litigation.
Snowflake Filing
Pomerantz LLP issues formal notice of class action filing against Snowflake Inc.
Trip.com Filing
Pomerantz LLP issues formal notice of class action filing against Trip.com Group Limited.
Gartner Filing
Pomerantz LLP issues formal notice of class action filing against Gartner, Inc.
Legal Alerts
Pomerantz LLP issues shareholder alerts for Driven Brands, CWH, and Apollo.
Enphase Suit Filed
Pomerantz LLP files class action litigation against Enphase Energy in federal court.
Shareholder Alerts Issued
Pomerantz LLP formally notifies shareholders of Driven Brands, Apollo, and CWH regarding pending litigation.
Litigation Expansion
Pomerantz confirms additional filings and alerts for Enphase and Nektar Therapeutics.
Enphase Energy Filing
Pomerantz LLP files a separate class action against Enphase Energy alleging securities fraud.
Navan reported a surprise profit in Q4 2026, with revenue reaching $178 million and a positive EPS of $0.02. The company is doubling down on AI-driven travel management and expects 24% growth in 2027, despite ongoing investor litigation.
Pomerantz LLP has initiated a class action lawsuit against Boston Scientific (BSX), alleging potential violations of federal securities laws. The litigation centers on the company's disclosures during a period of significant expansion and product integration, marking a critical legal challenge for the medical device giant.
Pomerantz LLP has initiated a class action investigation and filing against Boston Scientific Corporation (BSX), alleging the medical device giant made misleading statements regarding its clinical trials and business prospects. The litigation follows a period of heightened volatility for the company's cardiovascular portfolio, specifically concerning the FARAPULSE PFA system and recent trial adjustments.
Pomerantz LLP has issued a formal notice regarding a class action lawsuit against Boston Scientific Corporation (BSX), alleging potential securities fraud. The litigation focuses on whether the medical technology giant made misleading statements regarding its product pipeline or regulatory compliance during the class period.
Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Richtech Robotics and Mereo BioPharma, alleging securities fraud and misleading disclosures. These legal maneuvers highlight the increasing scrutiny on post-IPO startups and clinical-stage biotech firms facing market volatility.
Pomerantz LLP has issued a formal reminder regarding a class-action lawsuit filed against Mereo BioPharma Group plc, alleging potential violations of federal securities laws. The legal action focuses on whether the company made misleading statements or failed to disclose material facts regarding its clinical operations and financial outlook.
Pomerantz LLP has issued formal reminders regarding class action lawsuits filed against Mereo BioPharma and Richtech Robotics, signaling a surge in securities litigation within the biotech and automation sectors. These legal actions focus on alleged violations of federal securities laws, specifically regarding material misstatements that impacted investor valuations.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics and Enphase Energy, alleging securities fraud and misleading statements. These filings highlight a growing trend of legal scrutiny in the biotech and renewable energy sectors as companies navigate volatile market conditions and regulatory shifts.
Pomerantz LLP has filed a class action lawsuit against solar technology leader Enphase Energy, alleging securities law violations following a period of significant stock volatility. The litigation marks a critical regulatory challenge for the renewable energy sector as it navigates a broader market downturn.
Pomerantz LLP has initiated class action litigation against Nektar Therapeutics, alleging the company made false or misleading statements regarding its clinical programs and business prospects. The lawsuit seeks to recover damages for investors following significant stock volatility linked to the company's oncology pipeline performance.
Pomerantz LLP has issued urgent alerts to investors regarding class action lawsuits against Driven Brands, Apollo, and Camping World Holdings. These legal actions focus on alleged securities fraud and failures to disclose material information, potentially impacting institutional and retail recovery efforts.
Pomerantz LLP has initiated class action lawsuits against Nektar Therapeutics and Enphase Energy, alleging violations of federal securities laws. The litigation follows a series of financial disclosures and regulatory filings in early 2026 that triggered significant market volatility for both companies.
Pomerantz LLP has issued a series of alerts to shareholders regarding potential class action lawsuits against Driven Brands, Camping World Holdings, and Apollo-affiliated entities. The litigation follows significant financial disclosures, including Driven Brands' admission of material errors in prior financial statements.
Pomerantz LLP has initiated a series of class action filings against Gartner, Trip.com, and Snowflake, alleging violations of federal securities laws. These legal actions target corporate transparency and disclosure practices, signaling a heightened period of scrutiny for high-growth tech and consulting firms.
Pomerantz LLP has initiated legal proceedings against Eos Energy Enterprises following a massive 39% stock price decline triggered by manufacturing delays and a significant earnings miss. The class action alleges that the energy storage firm misled investors regarding its operational readiness and the scaling of its automated production lines.
Eos Energy (EOSE) is facing a significant class action lawsuit led by Pomerantz LLP following a 39% stock collapse and allegations of undisclosed manufacturing issues. The litigation centers on claims that the energy storage company misled investors regarding its operational scaling and financial forecasting accuracy.
Pomerantz Law Firm has initiated a class action against Gemini Space Station, Inc. (GEMI) and its leadership, alleging securities fraud. The legal action follows a turbulent week marked by a major stock crash, workforce reductions, and a controversial strategy shift.
Pomerantz LLP has filed a class action lawsuit against Gemini Space Station, Inc. (GEMI) and certain officers, alleging securities fraud or other unlawful business practices. The suit, filed in the United States District Court, seeks to recover damages for investors who purchased GEMI securities during the specified class period.
Pomerantz LLP has initiated securities class action investigations and filings against SaaS leader monday.com and travel giant Trip.com. The legal actions allege that the companies made materially false or misleading statements regarding their business operations and future prospects, leading to investor losses.
Pomerantz LLP has initiated securities class action lawsuits against SaaS leader monday.com and travel giant Trip.com, alleging potential disclosure failures. These legal challenges highlight the increasing scrutiny on high-growth tech and international travel platforms as they navigate volatile market conditions.